

CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE BLEND
ACTIVE SUBSTANCES:
- CJC-1295 (NO DAC) 5 MG
- IPAMORELIN 5 MG
FORM: 2 ML VIAL x 10 MG (LYOPHILIZED POWDER)
ACTIVE HALF-LIFE: CJC-1295: ~30 MIN; IPAMORELIN: ~2 HOURS
DOSAGE: 100-300 MCG, 1-3 TIMES PER DAY
ACNE: VERY LOW RISK
WATER RETENTION: VERY LOW RISK
HIGH BLOOD PRESSURE (HBP): VERY LOW RISK
HEPATOTOXICITY: NO RISK
AROMATIZATION: DOES NOT AROMATIZE
MANUFACTURER: DRAGON PHARMA
Dragon Pharma introduces the ultimate peptide combination for serious athletes: the CJC-1295 No DAC 5 mg/Ipamorelin 5 mg blend. This 10 mg synergistic formulation represents what many consider the "perfect peptide stack" for bodybuilders, fitness competitors, and performance enthusiasts seeking maximum natural growth hormone optimization. By combining a modified Growth Hormone-Releasing Hormone (GHRH) analog with a fifth-generation Growth Hormone-Releasing Peptide (GHRP), this blend creates a powerful, pulsatile release of Growth Hormone that closely mimics the body's natural production patterns, leading to exceptional body recomposition results with an outstanding safety profile.
The magic of this blend lies in the complementary action of its two components. CJC-1295 (without DAC) is a tetrasubstituted analogue of GHRH (1-29) that has been modified for increased potency and stability. The crucial distinction is the "No DAC" version, which has a short half-life (approximately 30 minutes) and creates a clean, pulsatile GH release rather than the continuous elevation seen with the DAC version. Ipamorelin is the most selective GHRP available, stimulating GH release without affecting cortisol, prolactin, or appetite levels. When administered together, they create a powerful synergistic effect—CJC-1295 primes the pituitary gland for release, while Ipamorelin provides the triggering signal. According to research on growth hormone secretagogues cited by the National Institutes of Health, this type of combined GHRH/GHRP approach can produce a GH release that is significantly greater than the sum of individual effects.
Each vial contains a total of 10 mg (5 mg CJC-1295 No DAC + 5 mg Ipamorelin) of pharmaceutical-grade lyophilized powder. Proper reconstitution is essential for maintaining peptide integrity. Using bacteriostatic water and a sterile syringe, slowly inject 1-2 mL of water into the vial, directing the stream against the glass wall. Gently swirl the vial until the powder is completely dissolved into a clear solution. Avoid shaking. Once reconstituted, refrigerate immediately (36°F-46°F) and use within 4-6 weeks.
The recommended dosage for this advanced blend ranges from 100 mcg to 300 mcg (total volume, containing equal ratios of each peptide) per injection. The pulsatile nature of this stack makes timing crucial for maximum effectiveness:
- Before Bed: The most important administration time to amplify the body's natural nocturnal GH pulse.
- Post-Workout: To shuttle nutrients into recovering muscle cells and kickstart the repair process.
- Upon Waking: To counteract the catabolic state of overnight fasting.
Injections should be administered subcutaneously and on an empty stomach. Wait at least 30-60 minutes after injection before eating, and allow 2 hours after meals before injecting. This prevents insulin spikes from interfering with GH release. For athletes looking to build substantial mass, this peptide foundation can be powerfully stacked with a mass-building compound like Sustanon 270 for synergistic gains in size and strength.
The CJC-1295 No DAC/Ipamorelin combination is widely regarded as the safest and most side-effect-free peptide protocol available. Key safety advantages include:
- No Desensitization: The pulsatile release pattern prevents pituitary gland desensitization, allowing for longer, more effective cycles compared to continuous GH secretagogues.
- No Hunger Stimulation: Unlike GHRP-6, Ipamorelin does not increase appetite, making it ideal for cutting phases.
- Hormonal Selectivity: Ipamorelin does not elevate cortisol or prolactin levels, avoiding unwanted hormonal side effects.
- No Aromatization or Hepatotoxicity: As non-steroidal peptides, they present zero risk of estrogen conversion or liver damage.
Potential side effects are minimal and may include mild tingling in extremities or temporary redness at injection sites. Since this stack does not suppress the HPTA axis, a traditional Post Cycle Therapy (PCT) is not required. However, if used as part of a comprehensive cycle including androgenic compounds, a proper PCT with Nolvadex should be implemented to restore natural testosterone production.
Dragon Pharma's commitment to excellence ensures that every vial of this premium blend meets the highest standards of purity and potency. Manufactured in cGMP-certified facilities, each batch undergoes rigorous third-party testing for authenticity, concentration accuracy, and sterility. This guarantees that you receive a product that delivers consistent, reliable results with every use. For advanced users seeking extreme conditioning, this peptide stack can be combined with a hardening agent like Masteron (Drostanolone Propionate) for unparalleled muscle density and definition.
In conclusion, the Dragon Pharma CJC-1295 No DAC/Ipamorelin 10 mg blend represents the cutting edge of peptide therapy for performance enhancement. Its ability to safely and effectively amplify the body's natural growth hormone production makes it an indispensable tool for athletes seeking to achieve new levels of muscular development, fat loss, and overall physical conditioning. Whether you're preparing for competition or pursuing personal transformation, this stack provides a scientifically-backed pathway to exceptional results.
This is a crucial distinction. CJC-1295 WITH DAC (Drug Affinity Complex) has a very long half-life (several days) and creates a continuous, elevated GH level that doesn't mimic natural pulsatile secretion. CJC-1295 WITHOUT DAC has a short half-life (~30 minutes) and creates sharp, pulsatile GH releases that closely resemble the body's natural pattern. The "No DAC" version is preferred for athletes as it prevents pituitary desensitization, allows for more natural feedback mechanisms, and is generally considered safer for long-term use.
This blend is significantly more advanced. While GHRP-6 and GHRP-2 are effective GH secretagogues, they lack the synergistic GHRH component (CJC-1295). Ipamorelin in this blend is more selective than GHRP-6/2—it doesn't cause hunger (like GHRP-6) or affect other hormones. The combination with CJC-1295 creates a much more powerful and natural GH release pattern, leading to better results with fewer side effects. It's considered the "next generation" of peptide therapy.
Due to its pulsatile nature and Ipamorelin's non-desensitizing properties, this stack can be run for longer cycles than many other peptides. A standard cycle lasts 12-16 weeks, followed by a 4-8 week break to allow receptor sensitivity to reset. Some users implement a 5-days-on, 2-days-off protocol throughout the cycle to further prevent any potential desensitization. Longer cycles of 6 months are possible with medical supervision, but for athletic use, 3-4 month cycles are optimal.
While peptides circulate systemically and don't cause true spot reduction, the powerful lipolytic effects of increased GH can lead to noticeable fat loss in stubborn areas, particularly the abdomen, love handles, and thighs. The metabolic enhancement and increased fat mobilization affect the entire body, but many users report particularly dramatic results in these problematic areas that are resistant to diet and exercise alone. For targeted fat loss, subcutaneous injections in fatty areas near your target zone are commonly practiced, though the effects remain systemic.
Please log in to write CJC 1295 NO DAC 5 MG/IPAMORELIN 5 MG review.
CLASSIFICATION: RECOMBINANT HUMAN GROWTH HORMONE (rHGH)
ACTIVE SUBSTANCE: SOMATROPIN
FORM: 1 PRE-FILLED PEN x 36 IU (12 MG)
ACTIVE HALF-LIFE: ~3.5 HOURS (SUBQ)
DOSAGE: 1–4 IU/DAY FOR ANTI-AGING; 4–8 IU/DAY FOR FAT LOSS OR PERFORMANCE
WATER RETENTION: POSSIBLE (DOSE DEPENDENT)
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PFIZER
CLASSIFICATION: RECOMBINANT HUMAN GROWTH HORMONE (r-hGH)
ACTIVE SUBSTANCE: SOMATROPIN (R-HGH)
FORM: 1 CARTRIDGE x 15 MG
ACTIVE HALF-LIFE: ~2–3 HOURS
DOSAGE: MEN 4-10 IU/DAY
ACNE: POSSIBLE
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): MAY INCREASE VIA FLUID RETENTION
HEPATOTOXICITY: NONE TYPICAL
AROMATIZATION: NONE
MANUFACTURER: NOVO NORDISK
CLASSIFICATION: GONADOTROPIN (LH RECEPTOR AGONIST)
ACTIVE SUBSTANCE: HUMAN CHORIONIC GONADOTROPIN
FORM: 1 LYOPHILIZED VIAL x 5000 IU + PROVIDED SOLVENT
ACTIVE HALF-LIFE: ~24–36 HOURS
DOSAGE: MEN 500-1000 IU
ACNE: POSSIBLE
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): MONITOR IF AT CV RISK
HEPATOTOXICITY: NONE TYPICAL
AROMATIZATION: INDIRECT
MANUFACTURER: IBSA
CLASSIFICATION: PEPTIDE HORMONE / HCG
ACTIVE SUBSTANCE: HUMAN CHORIONIC GONADOTROPIN
FORM: 1 ML AMP x 5000 IU
ACTIVE HALF-LIFE: ~3–6 DAYS
DOSAGE: 250–1000 IU 2–3x/WEEK (ON-CYCLE or PCT)
ACNE: POSSIBLE
WATER RETENTION: MODERATE
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NONE
AROMATIZATION: INDIRECTLY ELEVATES ESTROGEN
MANUFACTURER: SUN PHARMA
CLASSIFICATION: PEPTIDE HORMONE / HCG
ACTIVE SUBSTANCE: PRE-MIXED HUMAN CHORIONIC GONADOTROPIN
FORM: 1 VIAL x 10000 IU (READY-TO-INJECT)
ACTIVE HALF-LIFE: ~3–6 DAYS
DOSAGE: 250–1000 IU 2–3x/WEEK (ON-CYCLE or PCT)
ACNE: POSSIBLE
WATER RETENTION: LOW to MODERATE
HIGH BLOOD PRESSURE (HBP): RARE
HEPATOTOXICITY: NONE
AROMATIZATION: INDIRECTLY INCREASES ESTROGEN
MANUFACTURER: BHARAT SERUMS AND VACCINES